Enovix Co. (NASDAQ:ENVX) Shares Bought by Strong Tower Advisory Services

Strong Tower Advisory Services boosted its position in shares of Enovix Co. (NASDAQ:ENVX - Free Report) by 93.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 144,045 shares of the company's stock after buying an additional 69,435 shares during the period. Strong Tower Advisory Services owned 0.08% of Enovix worth $1,057,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC grew its stake in shares of Enovix by 376.9% in the 3rd quarter. Barclays PLC now owns 252,012 shares of the company's stock valued at $2,353,000 after purchasing an additional 199,166 shares during the last quarter. Fifth Third Bancorp grew its stake in shares of Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company's stock valued at $27,000 after purchasing an additional 1,000 shares during the last quarter. KBC Group NV grew its stake in shares of Enovix by 85.0% in the 4th quarter. KBC Group NV now owns 9,139 shares of the company's stock valued at $99,000 after purchasing an additional 4,200 shares during the last quarter. Caprock Group LLC purchased a new position in shares of Enovix in the 4th quarter valued at approximately $284,000. Finally, PBMares Wealth Management LLC grew its stake in shares of Enovix by 2.6% in the 4th quarter. PBMares Wealth Management LLC now owns 80,000 shares of the company's stock valued at $870,000 after purchasing an additional 2,000 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ENVX shares. B. Riley decreased their price target on Enovix from $17.00 to $12.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. Cantor Fitzgerald restated an "overweight" rating and issued a $30.00 price target on shares of Enovix in a research note on Thursday, February 20th. Benchmark decreased their price target on Enovix from $25.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, April 15th. JPMorgan Chase & Co. decreased their price target on Enovix from $10.00 to $9.00 and set an "overweight" rating on the stock in a research note on Thursday, May 1st. Finally, TD Securities decreased their price target on Enovix from $10.00 to $7.00 and set a "hold" rating on the stock in a research note on Thursday, May 1st. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, Enovix presently has an average rating of "Moderate Buy" and an average target price of $17.27.

Enovix Price Performance

Shares of NASDAQ ENVX traded down $0.27 during trading on Thursday, reaching $8.18. The company had a trading volume of 2,225,100 shares, compared to its average volume of 5,746,896. Enovix Co. has a twelve month low of $5.27 and a twelve month high of $18.68. The stock has a market capitalization of $1.57 billion, a PE ratio of -5.64 and a beta of 2.00. The stock has a 50-day moving average price of $6.92 and a two-hundred day moving average price of $8.96. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99.

Enovix Company Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.